Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias.

Charlotte B WagnerKelley JulianBaylee BryanMary N SteinbachSamuel ShewanLindsay MaxwellMeghan VigilGhulam Rehman MohyuddinAmandeep GodaraBrian McCluneGlicelda Galarza FortunaDouglas Sborov

Published in: Leukemia & lymphoma (2024)

Keyphrases

multiple myeloma
high dose
low dose
acute lymphoblastic leukemia
acute myeloid leukemia
single cell
cell therapy
diffuse large b cell lymphoma
combination therapy
squamous cell carcinoma
mesenchymal stem cells